Company: IONQ
Filing Date: 2025-08-11
Form Type: 424B7
Source: 0001193125-25-177997
Chunk: 51

Company: IonQ, Inc.
Filing Date: 2025-08-11
Form: 424B7
Chunk 51
---
,                             
 if you may not continuously exercise the warrants throughout that period, the specific date or dates on which you may exercise the warrants; |

| • |     | whether the warrants are to be sold separately or with other securities as parts of units; |

| • |     | whether the warrants will be issued in definitive or global form or in any combination of these forms, although,                         
 in any case, the form of a warrant included in a unit will correspond to the form of the unit and of any security included in that unit; |

| • |     | any applicable material U.S. federal income tax consequences; |

| • |     | the identity of the warrant agent for the warrants and of any other depositaries, execution or paying agents, 
 transfer agents, registrars or other agents;                                                                  |

| • |     | the proposed listing, if any, of the warrants or any securities purchasable upon exercise of the warrants on any 
 securities exchange;                                                                                             |

| • |     | the designation and terms of any equity securities purchasable upon exercise of the warrants; |

| • |     | the designation, aggregate principal amount, currency and terms of any debt securities that may be purchased upon 
 exercise of the warrants;                                                                                         |

| • |     | if applicable, the designation and terms of the debt securities, preferred stock, depositary shares or common 
 stock with which the warrants are issued and the number of warrants issued with each security;                |

| • |     | if applicable, the date from and after which any warrants issued as part of a unit and the related debt 
 securities, preferred stock, depositary shares or common stock will be separately transferable;         |

| • |     | the number of shares of preferred stock, the number of depositary shares or the number of shares of common stock 
 purchasable upon exercise of a warrant and the price at which those shares may be purchased;                     |

| • |     | if applicable, the minimum or maximum amount of the warrants that may be exercised at any one time; |

| • |     | information with respect to book-entry procedures, if any; |

| • |     | the antidilution provisions, and other provisions for changes to or adjustment in the exercise price, of the 
 warrants, if any;                                                                                            |

| • |     | any redemption or call provisions; and |

| • |     | any additional terms of the warrants, including terms, procedures and limitations relating to the exchange or 
 exercise of the